22nd century satisfies ip licensing and sponsored research obligations to ncsu through 2025 in an equity transaction

Mocksville, north carolina--(newsfile corp. - september 9, 2024) - 22nd century group, inc. (nasdaq: xxii), a tobacco products company leading the fight against nicotine addiction with its fda authorized 95% less nicotine brand vln®, today announced an agreement to fund all intellectual property, licensing and sponsored research payments to north carolina state university through 2025 in equity as part of a deal valued at over $1.2 million. the payments will occur over the course of three tranches, in equity or cash, at the company's election.
XXII Ratings Summary
XXII Quant Ranking